Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-12-2017 | Research

Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia

Authors: Mekuriaw Alemayehu, Mamo Wubshet, Nebiyu Mesfin, Aschalew Tamiru, Abebaw Gebayehu

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

Health-related quality of life (HRQoL) is an important outcome measure among HIV infected patients receiving antiretroviral therapy (ART). When HIV infected patients coinfected with Visceral Leishmaniasis (VL) the problem become severe because VL accelerates HIV replication and disease progression. The impact of VL on the quality of life of HIV infected patients has not been studied. In this study in Ethiopia, we compared the quality of life of HIV infected patients with and without VL.

Methods

A cross-sectional study was conducted from October 2015 to September 2016 in selected health centers and hospitals, in Northwest Ethiopia. Data on quality of life was collected by trained nurses. The instrument used to collect the data was the short Amharic version of the World Health Organization Quality of Life for HIV clients (WHOQoL-HIV). Depression was assessed using the validated version of Kessler scale. Data was entered and analyzed using SPSS version 20. Descriptive statistics, bivariate and multivariate linear regression model was used to summarize the results.

Results

A total of 590 study participants were included in the study with response rate of 95%. Of the 590 patients included in our study 125 (21%) were HIV-VL coinfection. HIV-VL coinfected patients had a lower quality of life in all the domains as compared to HIV patients without VL. Depression was consistently and strongly associated with all the quality of life domains of both groups. Also, in HIV infected patients a longer duration in ART was associated with higher HRQoL domains except for the spiritual and level of independence domains. With regard to HIV-VL coinfected patients, a longer duration in ART was associated with psychological, spiritual and level of independence domains of HRQoL. Demographics, clinical, and treatment characteristics resulted few significant associations with HRQoL domains of both groups.

Conclusion

HIV-VL coinfected patients had a poor quality of life in all the domains of the WHOQoL-HIV instrument. Depression, duration of ART and education were strongly associated with the quality of life. Depression should be targeted for intervention to improve the quality of life.
Literature
1.
Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95:239–43.CrossRefPubMed
2.
3.
Wolday D, Akuffo H, Demissie A, et al. Role of leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Infect Immun. 1999;67:5258–64.PubMedPubMedCentral
4.
Cruz I, Nieto J, Moreno J, Canavate C, et al. Leishmania/ HIV co-infections in the second decade. Indian J Med Res. 2006;123:357–88.PubMed
5.
Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97 Suppl 1:3–15.CrossRefPubMed
6.
7.
Alemayehu M, Wubshet M, Mesfin N, Gebayehu A. Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based crosssectional study. BMC Infect Dis. 2017;17:152.CrossRefPubMedPubMedCentral
8.
Sabin C. The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era. AIDS. 2002;16 Suppl 4:S61–8.CrossRefPubMed
9.
Wu W. Quality of life assessment comes of age in the era of highly active antiretroviral therapy. AIDS. 2000;14(10):1449–51.CrossRefPubMed
10.
Wilson I, Clearly P. Linking clinical variables with health related quality of life: A conceptual model of patient outcome. JAMA. 1995;273:53–6.CrossRef
11.
WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group Psychol Med. 1998;28:551–8.CrossRef
12.
Carrieri P, Spire B, Duran S, Katlama C, Peyramond D, François C, Chêne G, Lang J, Moatti J, Leport C, et al. Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;32(1):38–47.CrossRefPubMed
13.
Jia H, Uphold C, Wu S, Chen G, Duncan P. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Patient Care STDS. 2005;19(6):395–405.CrossRefPubMed
14.
Sarah A, Samar N, Abu-Saad HH, Jacques M. Quality of life in people living with HIV/AIDS in Lebanon. AIDS Care. 2010;22(6):687–96.CrossRef
15.
Deribew A, Deribe K, Reda A, Tesfay M, Hailmichael Y, Maja T, et al. Change in quality of life: a follow up study among patients with HIV infection with and without TB in Ethiopia. BMC Public Health. 2013;13:2013.CrossRef
16.
Deribew A, Tesfaye M, Hailmichael Y, Negussu N, Daba S, Wogi A, Belachew T, Apers L, Colebunders R. Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes. 2009;7:105.CrossRefPubMedPubMedCentral
17.
Legese LA, Mirjam AM, Sprangers J, Prins, Alemayehu W, Pythia T. Health-related quality of life of HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa. AIDS Care. 2015;27(8):934–45.CrossRef
18.
Selvaraj V, Ross MW, Unnikrishnan B, Supriya H. Association of quality of life with major depressive disorder among people with HIV in South India AIDS Care, doi:10.​1080/​0954012120126898​09 2012
19.
Rueda S, Raboud J, Mustard C, Bayoumi A, Lavis J, Rourke S. Employment status is associated with both physical and mental health quality of life in people living with HIV. AIDS Care. 2011;23(4):435–43.CrossRefPubMed
20.
Mannheimer S, Matts J, Telzak E, Chesney M, Child C, Wu A, Friedland G, Terry B. Community Programs for Clinical Research on AIDS. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10–22.CrossRefPubMed
21.
Mrus J, Williams P, Tsevat J, Cohn S, Wu A. Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res. 2005;14(2):479–91.CrossRefPubMed
22.
Casado A, Consiglio E, Podzamczer D, Badia X. Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients HIV. Clin Trials. 2001;2(6):477–83.
23.
Stangl A, Wamai N, Mermin J, Awor A, Bunnell R. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care. 2007;19(5):626–36.CrossRefPubMed
24.
25.
Amberbir A, Weldemichael K, Girma B. Predictors of adherence to antiretroviral therapy in Jimma hospital. Ethiopia: Master thesis Jimma University; 2007.
26.
FMOH. Guideline for diagnosis, treatment and prevention of Leishmaniasis in Ethiopia; 2013.
27.
WHO. Manual on visceral leishmaniasis. Report WHO/Leish/9640. Geneva: WHO; 1996.
28.
Meredith S, Kroon N, Sondorp E, et al. Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis. J Clin Microbiol. 1995;33:1742–5.PubMedPubMedCentral
29.
WHO. Technical, report: Control of the leishmaniasis. Geneva: Report of a meeting of the WHO expert committee; 2010.
30.
FMOH. Guidelines for management of opportunistic infections and antiretroviral treatment in adolescents and adults in Ethiopia. Federal HIV/AIDS prevention and control office and Federal Minsitry of Health; 2007.
31.
WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28:551–8.CrossRef
32.
Kessler R, Andrews G, Colpe L, Hiripi E, Mroczek D, Normand S, Walters E, Zaslavsky A. Short screening scales to monitor population prevalence and trends in non-specific psychological distress. Psychol Med. 2002;32:959–76.CrossRefPubMed
33.
Tesfaye M, Hanlon C, Wondimagegn D, Alem A. Detecting postnatal common mental disorders in Addis Ababa, Ethiopia: validation of the Edinburgh Postnatal Depression Scale and Kessler Scales. J Affect Disord. 2010;122(1–2):102–8.CrossRefPubMed
34.
Wubshet M, Berhane Y, Worku A, Kebede Y. Perception and predictors of quality of life among HIV patients attending ART clinics in Northwest Ethiopia. Aprospective longitudinal study: Ethiop Med J. 2014;52(3).
35.
Peltzer K, Ramlagan S. Percieved stigma among patients receiving antiretroviral therapy: A prospective study in KwaZulu-Natal. South Africa AIDS Care. 2011;23(1):60–8.CrossRefPubMed
36.
Casado A, et al. Highly active antiretroviral treatment (HAART) and health related quality of life in naïve and pretreated HIV infected patients. HIV Clin Trails. 2001;2:477–83.CrossRef
37.
Wouters E, et al. Physical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: A longitudinal study using structural equation modeling. BMC Public Health. 2009;9:103.CrossRefPubMedPubMedCentral
38.
Nokes K, Coleman C, Hamilton M, Corless I, Sefcik E, Kirksey K, et al. Age related effects on symptom status and health related quality of persons with HIV/AIDS. Appl Nurs Res. 2011;24(1):10–6.CrossRefPubMed
39.
Bray J, Campbell T. The family’s influence on health. In: Rakel RE, editor. Family Medicine. 7th ed. Philadelphia: Saunders Elsevier; 2007. p. 25–6.
40.
Razavi P, Hajifathalian K, Saeidi B, Djavid GE, Rasoulinejad M, Hajiabdolbaghi M, Paydary K, Kheirandish P, Foroughi M, Seyedalinaghi S, et al. Quality of life among persons with HIV/AIDS in Iran: internal reliability and validity of an international instrument and associated factors. AIDS Res. 2012;8(4):94–106.
41.
O’Connel K, Skevington S, Saxena S. Preliminary development of the World Health Organization’s Qulaity of Life HIV instrumment (WHOQOL-HIV): analysis of the pilot version. Soc Sci Med. 2003;57:1259–75.CrossRef
Metadata
Title
Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia
Authors
Mekuriaw Alemayehu
Mamo Wubshet
Nebiyu Mesfin
Aschalew Tamiru
Abebaw Gebayehu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0636-6

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue

Research

The Patient Assessment of Chronic Illness Care produces measurements along a single dimension: results from a Mokken analysis

Research

Health-related quality of life in persons with West Nile virus infection: a longitudinal cohort study

Research

Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life

Research

Post-traumatic stress disorder in parturients delivering by caesarean section and the implication of anaesthesia: a prospective cohort study

Research

The Kessler psychological distress scale: translation and validation of an Arabic version

Research

Psychometric evaluation of the Oswestry Disability Index in patients with chronic low back pain: factor and Mokken analyses